Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C12orf10 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MEN1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
AIP - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
FARSA - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
HYOU1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
EIF3B - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
PCNX3 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
UBQLN4 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GEO DataSets Profile neighbors
PRPF8 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GPR137 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
SEC24C - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
G6PC3 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
HNRNPUL1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
JADE2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
NDUFV1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
IP6K1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
ERGIC3 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
EIF4G1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
RNASEK - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on